← FDA Drug Approvals (Drugs@FDA)

ERYTHROMYCIN ETHYLSUCCINATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALPHARMA US PHARMS · Approved 1981-08-11

Drug application

FDA Application #
ANDA062200
Application type
Abbreviated New Drug Application (Generic)
Brand name
ERYTHROMYCIN ETHYLSUCCINATE
Generic name
Erythromycin Ethylsuccinate
Active ingredients
ERYTHROMYCIN ETHYLSUCCINATE
Dosage form
SUSPENSION
Route
ORAL
Marketing status
Discontinued
Sponsor
ALPHARMA US PHARMS
First approval
1981-08-11

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown